The Purpose of This Bidding Procedure is the Hiring of the Cmr Cardio-resonance Service... Tender

VALL HOSPITAL FOUNDATION OF 'HEBRON - RESEARCH INSTITUTE has floated a tender for The Purpose of This Bidding Procedure is the Hiring of the Cmr Cardio-resonance Service with Contrast to Patients (with Inclusion Criteria) of All Centers that Pa .... The project location is Spain and the tender is closing on 15 May 2024. The tender notice number is LICI 2024-024 SERVICIO RMC PROYECTO 202311-10, while the TOT Ref Number is 100658748. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Spain

Summary : The Purpose of This Bidding Procedure is the Hiring of the Cmr Cardio-resonance Service with Contrast to Patients (with Inclusion Criteria) of All Centers that Pa ...

Deadline : 15 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100658748

Document Ref. No. : LICI 2024-024 SERVICIO RMC PROYECTO 202311-10

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : EUR 98000.00

Purchaser's Detail

Purchaser : VALL HOSPITAL FOUNDATION OF 'HEBRON - RESEARCH INSTITUTE
Spain
Spain

Tender Details

Description: The object of this bidding procedure is the hiring of the CMR cardio-resonance service with contrast to patients (with inclusion criteria) of all centers that participate in the study to carry out the Studio entitled “Cardiovascular Toxicity in Early Human Epidermal Growth RECEPTOR FACTOR -2 - POSITION BREAST CANCER (HERBCA): FROM RISK EVALUATION TO PREVENTION (CAMAHER)” "destined for the Cardiovascular Disease Research Group of the University Hospital Hospital Vall Hebron - Institut de Recerca (VHIR), with the support of the La Mararató Foundation of TV3. The Cardiovascular Disease Research Group of the University Hospital Fundaciói Vall Hebron - Institut de Recerca (VHIR), requires to hire a cardiac magnetic resonance service with contrast, for patients included in the Camaher study, whose objective is to determine in cancer Of Mama Her2-positive the prognostic value of cardiomri and the usefulness of cardiovascular treatment to prevent moderate-severa cardiotoxicity.

Closing date: 2024-05-15

Bidding Bidding Budget: euros

...

Documents

 Tender Notice